MedTrace Logo

GABA Biomarkers in Dravet Syndrome

NCT05651204 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2022-12-14

No results posted yet for this study

Summary

This study will non-invasively obtain levels of GABA in the brain of children with SCN1A+DS and neurodeveloping children through evoked and induced cortical responses, correlate them with the BOLD responses, and with the levels of GABA in their blood.

Conditions

Interventions

DIAGNOSTIC_TEST

GABA Blood Level

Blood specimens will be collected by a registered phlebotomist according to hospital's specimen collection procedures.

Sponsors & Collaborators

  • Encoded Therapeutics

    collaborator INDUSTRY

  • Cook Children's Health Care System

    lead OTHER

Principal Investigators

  • Christos Papadelis, PhD · Cook Children's Health Care System

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-08
Primary Completion
2024-09-08
Completion
2027-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651204 on ClinicalTrials.gov